Mettler-Toledo International, Inc. $MTD Shares Sold by Whipplewood Advisors LLC

Whipplewood Advisors LLC cut its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 93.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 32 shares of the medical instruments supplier’s stock after selling 424 shares during the quarter. Whipplewood Advisors LLC’s holdings in Mettler-Toledo International were worth $38,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Mettler-Toledo International by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock worth $3,003,485,000 after buying an additional 30,535 shares during the last quarter. Alliancebernstein L.P. raised its position in Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after buying an additional 126,147 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after buying an additional 25,272 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its position in Mettler-Toledo International by 11.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock worth $479,673,000 after buying an additional 43,082 shares during the last quarter. Finally, PineStone Asset Management Inc. increased its holdings in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after purchasing an additional 98,737 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the company’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares of the company’s stock, valued at $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares in the company, valued at $368,154.70. The trade was a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock valued at $2,371,208 over the last 90 days. 0.77% of the stock is owned by insiders.

Mettler-Toledo International Stock Down 1.0%

Mettler-Toledo International stock opened at $1,420.12 on Tuesday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,454.68. The firm has a market capitalization of $29.25 billion, a price-to-earnings ratio of 35.96, a PEG ratio of 4.31 and a beta of 1.37. The company has a fifty day simple moving average of $1,299.33 and a 200-day simple moving average of $1,211.88.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the prior year, the firm earned $9.65 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on MTD shares. Barclays lifted their target price on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Evercore ISI lifted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.